- Home
- ARQT vs AVAH Comparison
ARQT vs AVAH Comparison
Compare ARQT & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARQT | AVAH |
|---|---|---|
| Founded | 2016 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hospital/Nursing Management |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 1.4B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARQT | AVAH |
|---|---|---|
| Price | $24.60 | $6.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 9 |
| Target Price | ★ $34.00 | $9.88 |
| AVG Volume (30 Days) | ★ 1.1M | 1.1M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 88.79 | ★ 1850.00 |
| EPS | N/A | ★ 1.05 |
| Revenue | $376,072,000.00 | ★ $2,433,199,000.00 |
| Revenue This Year | $34.46 | $7.31 |
| Revenue Next Year | $29.77 | $5.59 |
| P/E Ratio | ★ N/A | $6.32 |
| Revenue Growth | ★ 91.34 | 20.19 |
| 52 Week Low | $11.86 | $3.73 |
| 52 Week High | $31.77 | $10.32 |
Technical Indicators
Market Signals| Indicator | ARQT | AVAH |
|---|---|---|
| Relative Strength Index (RSI) | 55.71 | 44.55 |
| Support Level | $22.56 | $5.93 |
| Resistance Level | $25.03 | $7.52 |
| Average True Range (ATR) | 0.98 | 0.36 |
| MACD | 0.35 | 0.04 |
| Stochastic Oscillator | 97.77 | 54.00 |
Price Performance
Historical ComparisonAbout ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
About AVAH Aveanna Healthcare Holdings Inc.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.